Authors

  • Khodjiyeva D.T., Bafoyeva Z.B.

Keywords:

Parkinson’s disease; ketogenic diet; ketosis; biomarkers; depression; anxiety; quality of life; neuroprotection; clinical trials

References

de Lau LM, Breteler MM. Epidemiology of Parkinson’s disease. Lancet Neurol. 2006;5(6):525–535.

Schrag A, Jahanshahi M, Quinn N. What contributes to quality of life in patients with Parkinson’s disease? J Neurol Neurosurg Psychiatry. 2000; 69(3):308–312.

Paoli A, Rubini A, Volek JS, Grimaldi KA. Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets. Eur J Clin Nutr. 2013;67(8):789–796.

Newman JC, Verdin E. Ketone bodies as signaling metabolites. Trends Endocrinol Metab. 2014; 25(1):42–52.

Bough KJ, Rho JM. Anticonvulsant mechanisms of the ketogenic diet. Epilepsia. 2007;48(1): 43–58.

Gasior M, Rogawski MA, Hartman AL. Neuroprotective and disease-modifying effects of the ketogenic diet. Behav Pharmacol. 2006;17(5–6):431–439.

Masino SA, Rho JM. Mechanisms of ketogenic diet action. In: Noebels JL, et al., editors. Jasper’s Basic Mechanisms of the Epilepsies. 4th ed. Oxford University Press; 2012. p. 1–26.

Veech RL. The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions. Prostaglandins Leukot Essent Fatty Acids. 2004;70(3):309–319.

VanItallie TB, Nonas C, Di Rocco A, Boyar K, Hyams K, Heymsfield SB. Treatment of Parkinson disease with diet-induced hyperketonemia: a feasibility study. Neurology. 2005;64(4):728–730.

Phillips M, Murtagh DK, Gilbertson LJ, Asztely FJ, Lynch C. Low-fat vs ketogenic diet in Parkinson’s disease: a randomized controlled trial. Mov Disord. 2018;33(8):1303–1312.

Cheng B, et al. Anti-inflammatory effects of ketogenic diets in neurological disorders. Front Neurosci. 2020;14:608.

Sleiman SF, et al. Exercise promotes the expression of BDNF through the action of ketone bodies. PLoS One. 2016;11(3):e0153421.

Ruskin DN, Masino SA. The nervous system and metabolic dysregulation: therapeutic implications of the ketogenic diet. Front Neurosci. 2012; 6:72.

Taylor MK, Sullivan DK, Mahnken JD, Burns JM. Feasibility and efficacy of a ketogenic diet in Alzheimer’s disease. Alzheimers Dement. 2018; 14(12):1616–1623.

Kossoff EH, et al. Ketogenic diets: evidence for short- and long-term efficacy. Clin Neurol Neurosurg. 2013;115(5):639–646.